YOKNEAM, Israel, Aug. 1, 2024/ PRNewswire/-- InMode Ltd., a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended ...

Total Revenue: $86.4 million in Q2 2024; pro forma revenue was $102.6 million. GAAP Gross Margin: 80% in Q2 2024. Non-GAAP Gross Margin: 81% in Q2 2024; pro forma gross margin was 82%. International ...

Good morning and welcome to the InMode first-quarter 2024 earnings results conference call. [Operator instructions] Please note this event is being recorded. I would now like to hand the conference ...

Barclays analyst Matt Miksic lowered the firm’s price target on InMode to $27 from $29 and keeps an Overweight rating on the shares. The company’s preliminary Q3 sales were above consensus on a pro ...

YOKNEAM, Israel - InMode Ltd . (NASDAQ: NASDAQ: INMD), a global provider of medical technology, anticipates first-quarter revenue for 2024 to be between $80.0 million and $80.1 million, with pro forma ...

New York, New York--(Newsfile Corp. - April 28, 2025) - Eyes On Park, a leading optometry practice in Gramercy Park, announces the introduction of the cutting-edge Envision by InMode system for ...

On Thursday, Canaccord Genuity adjusted its outlook on shares of InMode Ltd . (NASDAQ:INMD), reducing the price target to $16 from the previous $21, while maintaining a Hold rating on the stock. The ...

*Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided ...

Therefore, we continue to provide pro forma results, which add to the non-GAAP results, the pre-order sales and related expenses. We believe that the pro forma results better reflect our business ...

Good day, and welcome to InMode's second quarter 2024 earnings results conference call. All participants will be in listen-only mode. [Operator instructions]. After today's presentation, there will be ...